Biomarkers In Kidney Disease (biomarkers In Disease: Methods, Discoveries And Applications)
by Victor R. Preedy /
2016 / English / PDF
18.5 MB Download
In some countries such as the United States, kidney disease kills
more people than cancers of the prostate or breast. In the United
States for example there are over 15 million individuals with
kidney disease. Translated to a worldwide basis, kidney disease of
various aetiologies represent a significant burden on healthcare
systems, affecting mortality, morbidity and also the family unit.
It is therefore imperative that appropriate use is made of
conventional, new and emerging biomarker platforms to aid
diagnosis, treatment and an understanding of outcome
measures.
In some countries such as the United States, kidney disease kills
more people than cancers of the prostate or breast. In the United
States for example there are over 15 million individuals with
kidney disease. Translated to a worldwide basis, kidney disease of
various aetiologies represent a significant burden on healthcare
systems, affecting mortality, morbidity and also the family unit.
It is therefore imperative that appropriate use is made of
conventional, new and emerging biomarker platforms to aid
diagnosis, treatment and an understanding of outcome
measures.Biomarkers in Kidney Disease
Biomarkers in Kidney Disease embraces a
holistic approach by combining information on different conditions
that affect the kidney and the use of biomarkers. Biomarkers are
described in terms of conventional, new and emerging analytes,
techniques, platforms and applications. It covers the latest
knowledge and trends. New platforms are described which combine
advances in biomedical sciences, physics, computing and chemistry.
embraces a
holistic approach by combining information on different conditions
that affect the kidney and the use of biomarkers. Biomarkers are
described in terms of conventional, new and emerging analytes,
techniques, platforms and applications. It covers the latest
knowledge and trends. New platforms are described which combine
advances in biomedical sciences, physics, computing and chemistry.
